Continental Advisors’s Celgene Corp CELG Stock Holding History

Continental Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-2,500	Closed	-$289K	–	185
2015 Q3	$270K	Buy	+2,500	New	+$310K	0.07%	150
2014 Q2	–	Sell	-7,000	Closed	-$532K	–	163
2014 Q1	$489K	Buy	+7,000	New	+$554K	0.13%	110
2013 Q3	–	Sell	-10,000	Closed	-$701K	–	145
2013 Q2	$585K	Buy	+10,000	New	+$602K	0.16%	101

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Continental Advisors's CELG Position: Q4 2015 in Review

Continental Advisors sold out of Celgene Corp (CELG) in Q4 2015, closing a stake of 2,500 shares — an estimated $289K sold.

Continental Advisors first reported a position in CELG in Q2 2013 and held it in 3 quarters. The position peaked at $585K in Q2 2013. 1,246 funds tracked by Wall St. Rank hold CELG as of Q4 2015.

Continental Advisors reported no remaining Celgene Corp position as of Q4 2015 after selling out during the quarter.
Continental Advisors sold 2,500 Celgene Corp shares in Q4 2015, an estimated $289K.
Continental Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 3 quarters.
Continental Advisors's Celgene Corp position peaked at $585K in Q2 2013.
1,246 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2015.

Based on Continental Advisors's 13F filing for Q4 2015, filed 12 Feb 2016.